NASDAQ:SGYP
Delisted

Synergy Pharmaceuticals Stock Signals

etoro logo Buy SGYP
*Your capital is at risk
$0.0064
+0 (+0%)
At Close: Sep 17, 2019

Latest Data & Signals Issued

Below are some of the latest signals issued for Synergy Pharmaceuticals

General

Signal Type Signal Value Data
Score 0.000 64 days ( 0 %
Last Price $0.0064 0 %
Performance History
7 Days
$0.0064 $0.0064
0%
30 Days
$0.0064 $0.0064
0%
12 Mos
$1.68 $0.0064
-99.62%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0064 - $0.0064
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Sep 16, 2019 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 37.01
Signal Type Signal Value Importance Data
Trend - 12 mos -75.25 % Very High Width: 145.59 %
Pred. range - 12 mos N/A - $0.0965 High -100.00 % - 1,407.43 %
Short MA 12 mos Buy Very High Apr 23, 2019 - 103 days
Long MA 12 mos Sell Very High Nov 30, -0001 - N/A days
Short/Long MA 12 mos Sell Very High Nov 30, -0001 - N/A days
Pivot Long Buy Low May 01, 2019 - 97 days
RSI Long Pivot Signal Buy Low May 22, 2019 - 82 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT SYNERGY PHARMACEUTICALS
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company is also developing SP-333,...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE